Elevance Health, Inc. (ELV) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and gover...
Elevance Health, Inc. (ELV) currently trades at a P/E ratio of 16.86 (historical range: 11.49–20.11, median: 15.09), placing it at the 84th percentile — expensive relative to its history, P/S ratio of 0.44 (range: 0.32–0.78, 54th percentile — near its historical average), EV/EBITDA of 36.59 (range: 8.82–39.08, 95th percentile).
Elevance Health, Inc. appears overvalued relative to its own historical valuation range, trading at elevated multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 16.86 | 11.49 | 15.09 | 20.11 | 84th | expensive relative to its history |
| P/S Ratio | 0.44 | 0.32 | 0.43 | 0.78 | 54th | near its historical average |
| EV/EBITDA | 36.59 | 8.82 | 12.60 | 39.08 | 95th | expensive relative to its history |
| FCF Yield | 0.05 | 0.01 | 0.04 | 0.06 | 68th | below its historical average |